/f/125658/4843x1496/b9b684dbb2/eapc-acronym-name-rgb.png)
Plasma galectin-3 as a novel biomarker to cardiac events in very high-risk atherosclerotic cardiovascular disease population: a prospective study in an upper-middle-income country
Event: ESC Preventive Cardiology 2024
Topic: Epidemiology, Prognosis, Outcome
Session: Understanding cardiovascular risk development: novel mechanisms (2)
